Barclays analyst Steve Valiquette lowered the firm’s price target on Walgreens Boots Alliance to $43 from $45 and keeps an Equal Weight rating on the shares. For fiscal Q2, channel checks are showing "more mixed" script growth trends and continued COVID headwinds, the analyst tells investors in a research note. As such, the firm expects "more muted" results.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on WBA:
- Walgreens Boots Alliance Inc. (WBA) Q2 Earnings Cheat Sheet
- Walgreens Boots Alliance price target lowered to $35 from $36 at Evercore ISI
- Walgreen Boots call volume above normal and directionally bullish
- Walgreens (WBA) Snagged in Political Drama Over Abortion Pill
- Walgreens stops offer abortion pill in 21 states, face blowback, NYTimes report
Questions or Comments about the article? Write to editor@tipranks.com